References
- Melchiorri C., Meliconi R., Frizziero L., Silvestri T., Pulsatelli L., Mazzetti I., et al. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum 1998; 41: 2165–74
- Vuolteenaho K., Moilanen T., al‐Saffar N., Knowles R. G., Moilanen E. Regulation of the nitric oxide production resulting from the glucocorticoid‐insensitive expression of iNOS in human osteoarthritic cartilage. Osteoarthritis Cartilage 2001; 9: 597–605
- Sakurai H., Kohsaka H., Liu M. F., Higashiyama H., Hirata Y., Kanno K., et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995; 96: 2357–63
- Moilanen E., Moilanen T., Knowles R., Charles I., Kadoya Y., al‐Saffar N., et al. Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am J Pathol 1997; 150: 881–7
- Farrell A. J., Blake D. R., Palmer R. M., Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992; 51: 1219–22
- Jarvinen T. A., Moilanen T., Jarvinen T. L., Moilanen E. Nitric oxide mediates interleukin‐1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage. Mediators Inflamm 1995; 4: 107–11
- Cao M., Westerhausen‐Larson A., Niyibizi C., Kavalkovich K., Georgescu H. I., Rizzo C. F., et al. Nitric oxide inhibits the synthesis of type‐II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target. Biochem J 1997; 324: 305–10
- Hashimoto S., Setareh M., Ochs R. L., Lotz M. Fas/Fas ligand expression and induction of apoptosis in chondrocytes. Arthritis Rheum 1997; 40: 1749–55
- Murrell G. A., Jang D., Williams R. J. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995; 206: 15–21
- Studer R. K., Georgescu H. I., Miller L. A., Evans C. H. Inhibition of transforming growth factor beta production by nitric oxide‐treated chondrocytes: implications for matrix synthesis. Arthritis Rheum 1999; 42: 248–57
- Vuolteenaho K., Moilanen T., Hamalainen M., Moilanen E. Regulation of nitric oxide production in osteoarthritic and rheumatoid cartilage. Role of endogenous IL‐1 inhibitors. Scand J Rheumatol 2003; 32: 19–24
- McCartney‐Francis N., Allen J. B., Mizel D. E., Albina J. E., Xie Q. W., Nathan C. F., et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993; 178: 749–54
- Pelletier J. P., Jovanovic D., Fernandes J. C., Manning P., Connor J. R., Currie M. G., et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 1998; 41: 1275–86
- van Beuningen H. M., Stoop R., Buma P., Takahashi N., van der Kraan P. M., van den Berg W. B. Phenotypic differences in murine chondrocyte cell lines derived from mature articular cartilage. Osteoarthritis Cartilage 2002; 10: 977–86
- Korhonen R., Kankaanranta H., Lahti A., Lahde M., Knowles R. G., Moilanen E. Bi‐directional effects of the elevation of intracellular calcium on the expression of inducible nitric oxide synthase in J774 macrophages exposed to low and to high concentrations of endotoxin. Biochem J 2001; 354: 351–8
- Xie Q. W., Kashiwabara Y., Nathan C. Role of transcription factor NF‐kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269: 4705–8
- Kleinert H., Schwarz P. M., Forstermann U. Regulation of the expression of inducible nitric oxide synthase. Biol Chem 2003; 384: 1343–64
- Yamashita M., Niki H., Yamada M., Mue S., Ohuchi K. Induction of nitric oxide synthase by lipopolysaccharide and its inhibition by auranofin in RAW 264.7 cells. Eur J Pharmacol 1997; 338: 151–8
- Hrabak A., Sefrioui H., Vercruysse V., Temesi A., Bajor T., Vray B. Action of chloroquine on nitric oxide production and parasite killing by macrophages. Eur J Pharmacol 1998; 354: 83–90
- Gerber R. C., Paulus H. E., Bluestone R., Pearson C. M. Clinical response and serum gold levels in chrysotherapy. Lack of correlation. Ann Rheum Dis 1972; 31: 308–10
- Tett S. E., Cutler D. J., Day R. O., Brown K. F. Bioavailability of hydroxychloroquine tablets in healthy volunteers. Br J Clin Pharmacol 1989; 27: 771–9